188 related articles for article (PubMed ID: 18006915)
1. Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status.
Garcia-Closas M; Troester MA; Qi Y; Langerød A; Yeager M; Lissowska J; Brinton L; Welch R; Peplonska B; Gerhard DS; Gram IT; Kristensen V; Børresen-Dale AL; Chanock S; Perou CM
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2269-75. PubMed ID: 18006915
[TBL] [Abstract][Full Text] [Related]
2. No evidence that GATA3 rs570613 SNP modifies breast cancer risk.
Johnatty SE; Couch FJ; Fredericksen Z; Tarrell R; Spurdle AB; Beesley J; Chen X; ; ; ; Gschwantler-Kaulich D; Singer CF; Fuerhauser C; Fink-Retter A; Domchek SM; Nathanson KL; Pankratz VS; Lindor NM; Godwin AK; Caligo MA; Hopper J; Southey MC; Giles GG; Justenhoven C; Brauch H; Hamann U; Ko YD; Heikkinen T; Aaltonen K; Aittomäki K; Blomqvist C; Nevanlinna H; Hall P; Czene K; Liu J; Peock S; Cook M; Platte R; Gareth Evans D; Lalloo F; Eeles R; Pichert G; Eccles D; Davidson R; Cole T; Cook J; Douglas F; Chu C; Hodgson S; Paterson J; Hogervorst FB; Rookus MA; Seynaeve C; Wijnen J; Vreeswijk M; Ligtenberg M; van der Luijt RB; van Os TA; Gille HJ; Blok MJ; ; Issacs C; Humphreys MK; McGuffog L; Healey S; Sinilnikova O; Antoniou AC; Easton DF; Chenevix-Trench G;
Breast Cancer Res Treat; 2009 Sep; 117(2):371-9. PubMed ID: 19082709
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
[TBL] [Abstract][Full Text] [Related]
4. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
Sung H; Lee KM; Choi JY; Han S; Lee JY; Li L; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
[TBL] [Abstract][Full Text] [Related]
5. Expression and mutational analysis of GATA3 in Malaysian breast carcinomas.
Bong PN; Zakaria Z; Muhammad R; Abdullah N; Ibrahim N; Emran NA; Syed Hussain SN
Malays J Pathol; 2010 Dec; 32(2):117-22. PubMed ID: 21329183
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.
Gaudet MM; Chanock S; Lissowska J; Berndt SI; Yang XR; Peplonska B; Brinton LA; Welch R; Yeager M; Bardin-Mikolajczak A; Sherman ME; Sutter TR; Garcia-Closas M
Pharmacogenet Genomics; 2006 Aug; 16(8):547-53. PubMed ID: 16847423
[TBL] [Abstract][Full Text] [Related]
8. Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.
Pooley KA; Healey CS; Smith PL; Pharoah PD; Thompson D; Tee L; West J; Jordan C; Easton DF; Ponder BA; Dunning AM
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):675-82. PubMed ID: 16614108
[TBL] [Abstract][Full Text] [Related]
9. Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.
Tinholt M; Viken MK; Dahm AE; Vollan HK; Sahlberg KK; Garred O; Børresen-Dale AL; Jacobsen AF; Kristensen V; Bukholm I; Kåresen R; Schlichting E; Skretting G; Lie BA; Sandset PM; Iversen N
BMC Cancer; 2014 Nov; 14():845. PubMed ID: 25407022
[TBL] [Abstract][Full Text] [Related]
10. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
[TBL] [Abstract][Full Text] [Related]
11. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.
Garcia-Closas M; Kristensen V; Langerød A; Qi Y; Yeager M; Burdett L; Welch R; Lissowska J; Peplonska B; Brinton L; Gerhard DS; Gram IT; Perou CM; Børresen-Dale AL; Chanock S
Int J Cancer; 2007 Dec; 121(11):2532-8. PubMed ID: 17683073
[TBL] [Abstract][Full Text] [Related]
12. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
Nordgard SH; Ritchie MD; Jensrud SD; Motsinger AA; Alnaes GI; Lemmon G; Berg M; Geisler S; Moore JH; Lønning PE; Børresen-Dale AL; Kristensen VN
Pharmacogenet Genomics; 2007 Feb; 17(2):127-36. PubMed ID: 17301692
[TBL] [Abstract][Full Text] [Related]
13. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
[TBL] [Abstract][Full Text] [Related]
14. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
[TBL] [Abstract][Full Text] [Related]
16. C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients.
Yamamoto-Ibusuki M; Yamamoto Y; Fujiwara S; Sueta A; Yamamoto S; Hayashi M; Tomiguchi M; Takeshita T; Iwase H
Eur J Hum Genet; 2015 Jul; 23(7):949-56. PubMed ID: 25370037
[TBL] [Abstract][Full Text] [Related]
17. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk.
Gaudet MM; Chanock S; Lissowska J; Berndt SI; Peplonska B; Brinton LA; Welch R; Yeager M; Bardin-Mikolajczak A; Garcia-Closas M
Cancer Res; 2006 Oct; 66(19):9781-5. PubMed ID: 17018638
[TBL] [Abstract][Full Text] [Related]
19. Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies.
Feigelson HS; Cox DG; Cann HM; Wacholder S; Kaaks R; Henderson BE; Albanes D; Altshuler D; Berglund G; Berrino F; Bingham S; Buring JE; Burtt NP; Calle EE; Chanock SJ; Clavel-Chapelon F; Colditz G; Diver WR; Freedman ML; Haiman CA; Hankinson SE; Hayes RB; Hirschhorn JN; Hunter D; Kolonel LN; Kraft P; LeMarchand L; Linseisen J; Modi W; Navarro C; Peeters PH; Pike MC; Riboli E; Setiawan VW; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D
Cancer Res; 2006 Feb; 66(4):2468-75. PubMed ID: 16489054
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.
Nyante SJ; Gammon MD; Kaufman JS; Bensen JT; Lin DY; Barnholtz-Sloan JS; Hu Y; He Q; Luo J; Millikan RC
Cancer Causes Control; 2015 Jan; 26(1):121-31. PubMed ID: 25421376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
